Key points are not available for this paper at this time.
In September 2007, President George W. Bush signed into law a bill requiring the registration of clinical trials in phase 2 or beyond and the public reporting of the results of those trials. This article reviews the initial implementation of the law and considers its strengths and weaknesses.
Alastair J.J. Wood (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: